IgG(+) Extracellular Vesicles Measure Therapeutic Response in Advanced Pancreatic Cancer

(1) Background: Pancreatic ductal adenocarcinoma (PDAC) is expected to be the second-leading cause of cancer deaths by 2030. Imaging techniques are the standard for monitoring the therapy response in PDAC, but these techniques have considerable limits, including delayed disease progression detection...

Descripción completa

Detalles Bibliográficos
Autores principales: Couto, Nuno, Elzanowska, Julia, Maia, Joana, Batista, Silvia, Pereira, Catarina Esteves, Beck, Hans Christian, Carvalho, Ana Sofia, Strano Moraes, Maria Carolina, Carvalho, Carlos, Oliveira, Manuela, Matthiesen, Rune, Costa-Silva, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496671/
https://www.ncbi.nlm.nih.gov/pubmed/36139375
http://dx.doi.org/10.3390/cells11182800

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496671/
https://www.ncbi.nlm.nih.gov/pubmed/36139375
http://dx.doi.org/10.3390/cells11182800

Ejemplares similares